Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

Meet Genomic Prediction, which provides advanced genetic testing for IVF. They have developed a novel, genome-wide molecular genotyping methodology for preimplantation genetic testing of embryos.

Dr. Nathan Treff, Chief Scientific Officer at Genomic Prediction, joins us to discuss the cutting-edge technology that offers IVF parents and families a cost-effective means to evaluate genetic risks due to chromosomal abnormalities, single-gene disorders, and multi-gene disorders, known as polygenic diseases such as diabetes, cancer, and heart disease.

Their approach provides an unparalleled level of options for identifying potential disease risk in embryos and improving newborn health outcomes.

For Genomic Prediction, it’s about helping IVF parents be more knowledgeable, showing them the risks and providing options to help make the best and most informed decisions for their families.

Health, Wealth, Beauty, and Business

Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]

iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.

There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.

Comments

comments